British Association for Cytopathology August 2025 Case Study
Calretinin Expression in High Grade Invasive Breast Carcinoma
Sarah Reeves Consultant Biomedical Scientist East Kent Hospitals University NHS Foundation Trust
Clinical information
- 35 year old female with history of breast lump in 2018
- Core biopsy in 2018 shows Grade 3 invasive ductal carcinoma, both ER and PR
negative - In 2024 attended breast clinic with rash and associated pain over right breast area
